Abbott Murex Anti-HCV (Version 4.0) - Taiwan Registration bd186be603a8ac442cc2d23b7a97e3d9
Access comprehensive regulatory information for Abbott Murex Anti-HCV (Version 4.0) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bd186be603a8ac442cc2d23b7a97e3d9 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
bd186be603a8ac442cc2d23b7a97e3d9
Ministry of Health Medical Device Import No. 032111
DHA05603211103
Product Details
This product uses enzyme immunoassay to test for hepatitis C virus (HCV) antibodies in human serum or plasma.
B Hematology and pathology devices
B4020 Analyze specific reagents
Imported from abroad
Dates and Status
Jan 10, 2019
Jan 10, 2024

